Hydrogel Biosensor: Implantable Nanotech to be Used in COVID Vaccines?

The Freedom Articles

An implantable hydrogel biosensor, made via a DARPA-Gates funded Silicon Valley company, appears to be slated to be used in the upcoming COVID vaccine. The US Department of Defense and the Bill and Melinda Gates Foundation have partnered with Profusa, a Silicon Valley company, to develop a piece of nanotechnology made out of hydrogel (similar to a soft contact lens) that can be injected and implanted under the skin using a vaccine as a delivery system. This sensor (or more accurately a biosensor), less than the size of a grain of rice, would effectively merge with the body. As a piece of nanotech, it would link up with the wireless network (the 5G-driven IoT or Internet of Things) and it would both transmit information about you and your body to authorities, as well as receive information. This article from Defense One was already reporting in March 2020 that the biosensor was on track to get FDA approval in early 2021, which is around the same time we have been told to expect the rollout of the COVID vaccine.

Profusa is another of these Silicon Valley companies with ties to the US Military Industrial Complex. It boasts on its website that it “is pioneering tissue-integrating biosensors for continuous monitoring of body chemistries.”